Resonant Therapeutics
PrivateLast Round
Grant
Sep 1, 2023
Total Funding Raised
$931,070
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Resonant Therapeutics is a biotechnology company that develops a drug discovery platform to identify novel tumor-selective targets and anti-tumor antibodies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Resonant Therapeutics Comparables
Compare Resonant Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kling Biotherapeutics | 77% | |
| Biolojic Design | 76% | |
| BigHat Biosciences | 72% |
Resonant Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Seed | Oct 15, 2015 |
Resonant Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Michigan Investment in New Technology Startups | Seed |
| Johnson & Johnson Innovation - JLABS | Grant |
| Mercury Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors grew 33% MoM.
- Apr 1, 2026
Monthly visitors grew 122% MoM.
Resonant Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Resonant Therapeutics's valuation, stock price, and market status.
Is Resonant Therapeutics a public or private company?
Resonant Therapeutics is a private company.
What is the current stock price of Resonant Therapeutics?
Resonant Therapeutics is a private company with no public stock price. Caplight tracks Resonant Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Resonant Therapeutics worth (valuation)?
Valuation information for Resonant Therapeutics is not publicly available.
Can I buy Resonant Therapeutics stock?
Resonant Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Resonant Therapeutics's last funding round?
Resonant Therapeutics's most recent funding round was Grant on September 1, 2023.
Who are the main investors in Resonant Therapeutics?
Key investors in Resonant Therapeutics include National Cancer Institute, Michigan Investment in New Technology Startups, Johnson & Johnson Innovation - JLABS, Mercury Fund.
Will Resonant Therapeutics IPO soon?
No public IPO plans have been announced for Resonant Therapeutics.
How can I track Resonant Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Resonant Therapeutics's secondary market activity and sign up for updates.